Ingen internetforbindelse — viser den gemte version af siden.

Alterity Therapeu…

AUAUD
← Til screeneren

Alterity Therapeutics Ltd (AU:ATH) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
alteritytherapeutics.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
MELBOURNE, Australia
Administrerende direktør
David A. Stamler
Ansatte
11
Udestående aktier
217.51 mio. pr. 2026-06-30
Free float
171.39 mio.
Markedsværdi
81.28 mio. AUD
Insidere
7.91%
Institutionelle investorer
17.98%
Branche (SIC)
Pharmaceutical Preparations
Beskrivelse

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Børser og tickere

BørsTickerValutaPrisType
AU Australian Securities ExchangeATH primærAUD0.355 -2.74%almindelige aktier
US USA StocksPRNAF OTCUSD0.4 +0.00%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
Meltzer (Brian Derek) (F…≈49.36%9.42 mio.2025-11-21
Gozlan (Lawrence) (Direc…≈23.83%4.55 mio.2025-04-07
Marks (Peter Vincent) (I…≈1.19%227 7042026-08-31
Twin Lakes Capital Manag…0.73%139 2582026-06-30
Morgan Stanley0.33%63 0652026-06-30
Greenleaf Trust0.32%62 0002026-06-30
HB Wealth Management, LL…0.31%58 4602026-06-30
Citadel Advisors Llc0.2%37 5972026-06-30
Kempler (Geoffrey Paul)…≈0.16%30 0002025-11-21
HRT Financial LP0.09%17 2922026-06-30
BNP Paribas Financial Ma…0.05%10 2392026-06-30
Gamma Investing LLC0.01%2 3092026-06-30
Rhumbline Advisers0.01%2 0092026-06-30
Acadian Asset Management…0.01%1 8632026-06-30
Fidelity Concord Street…0.01%1 1552026-05-31
Stamler (David) (Chief E…—91.69 mio.2025-11-21